McCoy, Rozalina G. http://orcid.org/0000-0002-2289-3183
Herrin, Jeph
Swarna, Kavya Sindhu
Deng, Yihong
Kent, David M.
Ross, Joseph S. http://orcid.org/0000-0002-9218-3320
Umpierrez, Guillermo E. http://orcid.org/0000-0002-3252-5026
Galindo, Rodolfo J.
Crown, William H.
Borah, Bijan J.
Montori, Victor M.
Brito, Juan P.
Neumiller, Joshua J.
Mickelson, Mindy M.
Polley, Eric C.
Funding for this research was provided by:
Patient-Centered Outcomes Research Institute (PCS-1409-24099, PCS-1409-24099, PCS-1409-24099, PCS-1409-24099, PCS-1409-24099, PCS-1409-24099, PCS-1409-24099, PCS-1409-24099, PCS-1409-24099, PCS-1409-24099, PCS-1409-24099)
Article History
Received: 14 June 2023
Accepted: 22 February 2024
First Online: 3 April 2024
Competing interests
: G.E.U. reports unrestricted support for research studies to Emory University from Dexcom, Abbott and Bayer, and serves on the advisory board of Directors for GlyCare. R.J.G. has received unrestricted research support (to Emory University) from Novo Nordisk, Eli Lilly and Dexcom, and consulting fees from Sanofi, Novo Nordisk, Eli Lilly, Pfizer, Boehringer, Bayer and Weight Watchers. W.H.C. has received unrestricted research consulting support from Janssen Scientific Affairs LLC, Viatris, Merck and Optum. J.J.N. reports serving as a consultant to Sanofi, Bayer, Eli Lilly and Boehringer Ingelheim. The other authors declare no competing interests.